Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Fleck

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Pharmacology|March 22, 2002
Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administrationStanley D Glick, Isabelle M Maisonneuve, Barbara A Kitchen, et al.
Neuropharmacology|May 4, 2016
Mutagenesis and computational docking studies support the existence of a histamine binding site at the extracellular β3+β3- interface of homooligomeric β3 GABAA receptorsPaul Hoerbelt, Joachim Ramerstorfer, Margot Ernst, et al.
European Journal of Pharmacology|June 5, 2004
Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administrationChristopher J Pace, Stanley D Glick, Isabelle M Maisonneuve, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Pharmacology|March 22, 2002
Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administrationStanley D Glick, Isabelle M Maisonneuve, Barbara A Kitchen, et al.
Neuropharmacology|May 4, 2016
Mutagenesis and computational docking studies support the existence of a histamine binding site at the extracellular β3+β3- interface of homooligomeric β3 GABAA receptorsPaul Hoerbelt, Joachim Ramerstorfer, Margot Ernst, et al.
European Journal of Pharmacology|June 5, 2004
Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administrationChristopher J Pace, Stanley D Glick, Isabelle M Maisonneuve, et al.
Pageof 2